oral hypoglycemic agent
Jump to navigation
Jump to search
Introduction
Hypoglycemic agents taken by mouth.
Indications
- treatment of diabetes mellitus type 2
Adverse effects
* hypoglycemic agents least likely to cause hypoglycemia
- metformin
- SGLT2 inhibitors (flozins)
- GLP-1 receptor agonists (incretin mimetics, glutides)
- tirzepatide
- thiazolidinediones (glitazones)
- dipeptidyl peptidase-4 inhibitors (gliptins)
Laboratory
More general terms
More specific terms
- alpha glucosidase inhibitor
- gliptin; dipeptidyl peptidase-4 inhibitor; DPP-4 inhibitor
- glitazar
- meglitinide (Meglitinido, Meglitinidum)
- metformin (Glucophage)
- oral insulin
- SGLT-2 inhibitor; oral glucosuric agent; flozin
- sulfonylurea
- thiazolidinedione; glitazone; TZD
References
- ↑ NEJM Knowledge+ Endocrinology